Merck & Co., Inc. (MRK)
MRKNYSEBiotechnology: Pharmaceutical Preparations
$148.75
+2.02 (+1.38%) today
Closed, Nov 9, 4:03 PM ET
- Market cap
- $366.68bn
- P/E
- 47.7
- EPS, last 4 quarters
- $3.12
- Dividend yield
- –
- Day range
- –
- 52-week range
- $84.35 to $156.92
- Average volume
- 8.55m
- Previous close
- $146.73
Analysts
22 coveringBuy15 buy, 7 hold, 0 sell
Targets a year out average $162.14, +9.0% from here
Earnings
next estimate $1.78Next report
Dec 2025
+0.5%
Mar 2026
+15.2%
Jun 2026
+50.0%
Sep 2026
+17.4%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $16.40bn | $16.29bn | $16.61bn | $18.09bn |
| Gross profit | $10.85bn | $12.09bn | $12.21bn | $13.19bn |
| Operating income | $3.85bn | -$3.40bn | -$584.00m | $5.58bn |
| Net income | $2.96bn | -$4.24bn | -$1.33bn | $5.07bn |
Last four quarters: revenue $67.38bn, margin 3.6%, free cash flow $14.75bn
News
8 latest- Can Moderna's First Cancer Therapy Win FDA Approval in 2027?Zacks · 9 hours ago
- INVA or MRK: Which Is the Better Value Stock Right Now?Zacks · 10 hours ago
- Will Bristol Myers' Growth Brands Offset Eliquis Headwinds?Zacks · 13 hours ago
- MRK's 2027 Outlook Challenging, Long-Term Prospects PromisingZacks · 13 hours ago
- Zacks Investment Ideas feature highlights: Moderna, AbbVie, Eli Lilly and MerckZacks · 17 hours ago
- Moderna (MRNA) Stock Hits 52-Week Highs After Q3 Earnings: Buy, Hold, or Sell?Zacks · 3 days ago
- Merck Stock Shows Sustained Strength: Time to Buy, Sell or Hold?Zacks · 3 days ago
- MRNA Q3 Earnings Beat on COVID Sales, Raises '26 Outlook, Stock RisesZacks · 3 days ago
The company
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world - and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NYSE
- Region
- North America
- Website
- merck.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.